Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.


Journal

Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria
ISSN: 1984-2961
Titre abrégé: Rev Bras Parasitol Vet
Pays: Brazil
ID NLM: 9440482

Informations de publication

Date de publication:
2021
Historique:
received: 09 10 2020
accepted: 20 01 2021
entrez: 31 3 2021
pubmed: 1 4 2021
medline: 10 4 2021
Statut: epublish

Résumé

Neospora caninum is an apicomplexan parasite that causes abortion in cattle, resulting in significant economic losses. There is no commercial treatment for neosporosis, and drug repositioning is a fast strategy to test possible candidates against N. caninum. In this article, we describe the effects of atovaquone, chloroquine, quinine, primaquine and tetracycline on N. caninum proliferation. The IC50 concentrations in N. caninum were compared to the current information based on previous studies for Plasmodium and Toxoplasma gondii, correlating to the described mechanisms of action of each tested drug. The inhibitory patterns indicate similarities and differences among N. caninum, Plasmodium and T. gondii. For example, atovaquone demonstrates high antiparasitic activity in all the analyzed models, while chloroquine does not inhibit N. caninum. On the other hand, tetracycline is effective against Plasmodium and N. caninum, despite its low activity in T. gondii models. The repurposing of antimalarial drugs in N. caninum is a fast and inexpensive way to develop novel formulations using well-established compounds.

Identifiants

pubmed: 33787719
pii: S1984-29612021000100312
doi: 10.1590/S1984-29612021006
pii:
doi:

Substances chimiques

Antimalarials 0
Tetracyclines 0
Chloroquine 886U3H6UFF
Quinine A7V27PHC7A
Primaquine MVR3634GX1
Atovaquone Y883P1Z2LT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e022120

Auteurs

Luiz Miguel Pereira (LM)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Gabriela de Luca (G)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Nathália de Lima Martins Abichabki (NLM)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Jade Cabestre Venancio Brochi (JCV)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Luciana Baroni (L)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Péricles Gama Abreu-Filho (PG)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Ana Patrícia Yatsuda (AP)

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brasil.

Articles similaires

Humans Female Pregnancy Adult Cameroon
1.00
Antimalarials Plasmodium falciparum Aminoquinolines Protozoan Proteins Humans
Uganda COVID-19 Humans Malaria Interrupted Time Series Analysis
Chloroquine Malaria, Vivax Plasmodium vivax Nucleic Acid Amplification Techniques Drug Resistance

Classifications MeSH